 Home > Medical News > Latest Medical News > Kintor Pharma Announces Completion of Subject Enrollment in China Phase II Clinical Trial of Furitax for the Treatment of Female Hair Loss

Kintor Pharma Announces Completion of Subject Enrollment in China Phase II Clinical Trial of Furitax for the Treatment of Female Hair Loss

 Last Update: 2022-05-27
 Source: Internet
 Author: User

Tags

hair dandruff shampoo

type ii

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

SUZHOU, March 7, 2022 /PRNewswire/ -- On March 6, 2022, Beijing time, Kintor Pharma announced that its self-developed and potentially first-of-its-kind furitan is an effective treatment for female androgenetic alopecia (AGA).

In recent years, with the increase in the number of people with hair loss, the trend of hair loss is becoming more and more obvious, and the problem of hair loss is gradually becoming the focus of the whole society

Dr.

China Phase II Clinical Trial of Freytan for the Treatment of Female Androgenetic Alopecia

This Phase II clinical trial is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of furatan in the treatment of adult female patients with androgenetic alopecia

*Guidelines for the diagnosis and treatment of androgenetic alopecia in China

About Furitane

Furytan, an androgen receptor antagonist, is a potential first-in-class topical drug for the treatment of androgenetic alopecia and acne

Source: Kintor Pharmaceuticals

The original is abridged

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.